Rivus Pharmaceuticals Inc., a drug developer focused on obesity treatments, is considering a US initial public offering as ...

Europastry is among the biggest suppliers of frozen bread used by coffee chains worldwide. Its IPO could propel its dynasty's ...

Flutterwave CEO GB discusses the company's recent administrative changes, product focus, and their implications for the ...

The U.S. initial public offering market is expected to welcome nine deals this week to raise about $1.4 billion, anchored by kindergarten operator KinderCare Learnings Cos. Inc. and Brazilian company ...

Tokyo Metro set a tentative initial public offering (IPO) range of 1,100 to 1,200 yen per share, against an initial estimate ...

Joint fund manager Bertie reflects on the pink glow of capital markets and the surge of IPOs and QIPs while pondering AI’s ...

RNA biotech CAMP4 Therapeutics has marked out plans for a $67 million IPO, with inflammation-focused Upstream Bio pegging its ...

Like Upstream, Camp4 filed plans with the U.S. Securities and Exchange Commission in September to hold its upcoming IPO. It intends to list on Nasdaq as “CAMP.” After its founding in 2016, Camp4 went ...

Seven IPOs debuted in the US this past week, raising a combined $1.8 billion. Six companies submitted initial filings this ...

Septerna, Inc. aims to raise $100 million in an IPO to advance its clinical-stage biopharma treatments for endocrine diseases ...

Masan Consumer (Stock code: MCH) announced Resolution of the Board of Directors approving the transfer of MCH shares from ...

Utica Shale E&P Infinity Natural Resources has not yet set a price or disclosed the number of shares it intends to offer.